SYNCADOL® Provides Front-Line Defenses During Cold and Flu Season
SYNEVIT®'s Potent, Optimized Vitamin D3 Supplement Is Designed to Strengthen the Body and Boost the Immune System
"The best way to defend the body from illness is by strengthening its own natural defense systems," said
Over time, studies have repeatedly demonstrated the efficacy of vitamin D3 as a way to ward off illnesses. One study in 2009 linked low vitamin D levels to the prevalence of cold and flu symptoms. Another report in 2017 from the Harvard Gazette shared that large-scale studies found daily or weekly doses of vitamin D can help fight acute respiratory infections. Yet another study from 2020 connected vitamin D3 with successfully lowering the risk of contracting the flu and COVID-19.
SYNCADOL® was developed with studies like these in mind. It delivers a clean, natural form of vitamin D3 (as cholecalciferol) as a daily supplement. As is the case with all of SYNEVIT®'s supplements, SYNCADOL® is designed with careful attention to things like concentration, absorption, and bioavailability.
Recommended daily allowance (RDA) is also observed. "We aim to provide a clean, concentrated dose that doesn't overwhelm the body with too much vitamin D3," said Cvetkovski. "The body needs enough to work with. Providing more than that, even with a relatively safe supplement like vitamin D3, is reckless and can even be dangerous."
The research backs up this sentiment. For instance, Mount Sinai Health System suggests 4,000 IU/day as an upper limit to avoid vitamin D toxicity. SYNCADOL® delivers a clean 2,000 IU dose daily. This gives the body plenty of vitamin D support without being excessive.
The best way to protect against cold, flu, and other common illnesses is to help the body help itself. Quality supplements like SYNCADOL® have the potential to bolster the immune system, giving individuals a better chance to navigate the cold and flu season in good health.
About SYNEVIT®
Launched in 1998 by CEO
Media Contact:
[email protected]
(02) 3225 843
View original content:https://www.prnewswire.com/news-releases/syncadol-provides-front-line-defenses-during-cold-and-flu-season-302368436.html
SOURCE Synevit
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RoboSense Announces H1 2026 LiDAR Sales of 719,200 Units as Robotics Segment Grows by 510.4%
- Hytera Introduces PDC580 Dual-Mode Rugged Radio to Support Seamless Communication Across Critical Operations
- XTransfer recognised in The Payments Power 50 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share